Projects
This page shows the 200 projects that have been approved to run in OpenSAFELY.
Projects numbered 1-155 were approved during the COVID-19 pandemic under legal powers issued by the Secretary of State: Regulation 3(4) of the Health Service (Control of Patient Information) Regulations 2002 – COPI Regulations. Under this emergency legal power, the Type 1 Opt-out [archived here] (which a patient can register with their GP surgery to prevent their GP data from being shared outside the GP practice for planning or research purposes) was not required to be upheld for research and planning purposes in the pandemic. Therefore, for projects 1-155 a patient who had registered a Type 1 Opt-out could have had their GP health information used (anonymously) in these projects.
In June 2023, the legal basis for OpenSAFELY’s operation changed [archived here] from the emergency COPI Regulations to the COVID-19 Public Health Directions 2020. Under this Direction, the Type 1 Opt-out will be upheld for all new projects (after 155).
In June 2025, the government issued new Directions that make it possible to conduct research on any healthcare topic. As such, projects after number 205 are not confined to COVID-19 studies and cover a wide range of health topics.
OpenSAFELY Projects
Search for a project →-
Project #146: Scarlet fever and invasive group A strep cases during the COVID-19 pandemic
Service evaluation project run by University of Oxford.
COVID-19 -
Project #145: Association between ursodeoxycholic acid and COVID-19 outcomes
Research project run by London School of Hygiene and Tropical Medicine.
COVID-19 -
Project #144: COVID-19 impact on anastrazole use by post-menopausal women with hormone-dependent breast cancer
Service evaluation project run by NHS England.
COVID-19 -
Project #143: Comparison of risk factors for hospitalizations and death from winter infections
Research project run by University of Bristol, University of Cambridge, and University of Oxford.
COVID-19 -
Project #142: The impact of COVID-19 on prescribing of antimicrobials
Audit, and service evaluation project run by University of Oxford.
COVID-19 -
Project #141: The impact of COVID-19 on the care of people with sickle cell disease
Service evaluation project run by University of Oxford.
COVID-19 -
Project #140: Incidence and management of gout during and before the COVID-19 pandemic
Service evaluation project run by Kings College London.
COVID-19 -
Project #139: Risk factors for COVID-19 disease progression in immunocompromised populations
Research project run by London School of Hygiene & Tropical Medicine.
COVID-19 -
Project #138: Hypertension and blood pressure in the Quality and Outcomes Framework (QOF)
Service evaluation project run by University of Oxford.
COVID-19 -
Project #137: Healthcare needs for people with chronic kidney disease in the COVID-19 era
Research, and service evaluation project run by London School of Hygiene & Tropical Medicine.
COVID-19 -
Project #136: GP appointments during COVID
Service evaluation project run by University of Oxford.
COVID-19 -
Project #135: Impact of COVID-19 on diabetes care in England
Audit, and service evaluation project run by University of Oxford.
COVID-19 -
Project #134: Impact of COVID-19 in people with chronic lymphocytic leukaemia
Research project run by University of Oxford.
COVID-19 -
Project #133: Effect of COVID-19 on prescribing of Dependence Forming Medicines and the associated health utilisation
Service evaluation project run by PrescQIPP C.I.C..
COVID-19 -
Project #132: Assessing the Impact of COVID-19 on QOF registered patients and health groups that experience inequalities
Service evaluation project run by NHS England.
COVID-19 -
Project #131: SLE and COVID-19
Research project run by Swansea University.
COVID-19 -
Project #130: Surveillance of psychiatric emergencies over time to investigate the effect of COVID-19 on mental health. A cohort study using OpenSafely
Audit project run by University of Surrey.
COVID-19 -
Project #129: Curation of GP appointments data
Audit project run by University of Oxford.
COVID-19 -
Project #128: The effect of COVID-19 infection and vaccination on PSA levels in men
Research project run by University of Surrey.
COVID-19 -
Project #127: Prostate cancer incidence and prevalence in the COVID-19 pandemic
Service evaluation project run by University of Surrey.
COVID-19 -
Project #126: The impact of the COVID-19 pandemic on Antipsychotic Prescribing in at risk groups
Research project run by Oxford Health NHS Foundation Trust.
COVID-19 -
Project #125: What was the impact of the COVID-19 pandemic on medication reviews?
Service evaluation project run by University of Oxford and London School of Hygiene and Tropical Medicine.
COVID-19 -
Project #124: Describing patterns of BMI recordings in primary care records
Research project run by University of Oxford and London School of Hygiene and Tropical Medicine.
COVID-19 -
Project #123: PINCER change detection
Audit project run by University of Oxford and London School of Hygiene and Tropical Medicine.
COVID-19 -
Project #122: Opioid prescribing trends and changes during COVID-19
Research project run by University of Oxford and London School of Hygiene and Tropical Medicine.
COVID-19 -
Project #121: PHOSP
Research project run by University of Leeds.
COVID-19 -
Project #120: Long-term kidney outcomes following hospitalisation with Covid-19
Research project run by University of Oxford, London School of Hygiene and Tropical Medicine and University of Glasgow.
COVID-19 -
Project #119: The healthcare utilisation of people with long COVID
Research project run by University of Oxford and London School of Hygiene and Tropical Medicine.
COVID-19 -
Project #118: Expected Background Rates of Clinical Events in Immunocompromised Patients
Research project run by University of Oxford and London School of Hygiene and Tropical Medicine.
COVID-19 -
Project #117: Understanding and adjusting for bias in OpenSAFELY COVID testing data
Research project run by University of Oxford, London School of Hygiene and Tropical Medicine, and Office for National Statistics.
COVID-19